Certara enhances SYBYL-X drug design and discovery software suite

Certara has released version 2.1 of its SYBYL-X molecular modeling and simulation suite.

Certara


Certara has released version 2.1 of its SYBYL-X molecularmodeling and simulation suite. SYBYL-X 2.1 features a new job control systemthat provides a consistent interface across the entire tool suite. This changeallows jobs to be submitted remotely from Windows, Linux or Mac to any Linuxsystem where SYBYL-X is installed. Certara's QSAR technology is also moreaccessible now.

Certara


Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

February 2023 Front Cover

Latest Issue  

• Volume 19 • Issue 2 • February 2023

February 2023

February 2023 Issue